Subscribe To
Eyenovia Announces $12 Million Registered Direct Offering
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic technology company commercializing Mydcombi™ (tropicamide+phenylephrine ophthalmic spray for mydriasis) and developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today […] The post Eyenovia Announces $12 Million Registered Direct Offer...
Read More
Posted: Aug 24 2023, 22:47
Author Name: forextv
Views: 111711